Fund shareholders of ALNYLAM PHARMACEUTICALS INC
ISIN US02043Q1076 · United States · LEI 529900S3ZI14OWRJII50
- Fund shareholders
- 737
- Of which ETFs
- 212 525 other funds
- Value held
- ≈ 21.6B $ 21.5B $ · 1.4B SEK · 14.6M €
- Share of capital
- 56.4 % of 133.8M shares on Jul 24, 2026
737 funds hold this company. This table lists the 733 that declare it in a regulatory filing. The other 4 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Growth Fund of America Growth Fund of America | 7,670,994 | 2.3B $ | 0.64 % | 5.73 % | as of May 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,239,087 | 1.3B $ | 0.06 % | 3.17 % | as of Jun 30, 2026 ↗ |
| AMCAP Fund AMCAP Fund | 4,101,680 | 1.2B $ | 1.27 % | 3.07 % | as of May 31, 2026 ↗ |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,893,030 | 870.9M $ | 0.39 % | 2.16 % | as of Jun 30, 2026 ↗ |
| Invesco QQQ Trust, Series 1 Invesco QQQ Trust, Series 1 | 2,834,095 | 853.1M $ | 0.17 % | 2.12 % | as of Jun 30, 2026 ↗ |
| Fidelity OTC Portfolio Fidelity Securities Fund | 2,140,824 | 440M $ | 1.02 % | 1.60 % | as of Jul 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 2,136,580 | 439.1M $ | 1.15 % | 1.60 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 2,034,761 | 612.5M $ | 0.87 % | 1.52 % | as of Jun 30, 2026 ↗ |
| VANGUARD GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,624,001 | 488.9M $ | 0.13 % | 1.21 % | as of Jun 30, 2026 ↗ |
| Investment Co of America Investment Co of America | 1,612,942 | 485.5M $ | 0.26 % | 1.21 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,530,865 | 460.8M $ | 0.47 % | 1.14 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 1,338,874 | 404.3M $ | 0.41 % | 1.00 % | as of May 31, 2026 ↗ |
| Dodge & Cox Stock Fund Dodge & Cox Funds | 1,233,200 | 371.2M $ | 0.31 % | 0.92 % | as of Jun 30, 2026 ↗ |
| Growth Fund AMERICAN FUNDS INSURANCE SERIES | 1,197,876 | 360.6M $ | 0.63 % | 0.90 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 1,165,773 | 350.9M $ | 1.52 % | 0.87 % | as of Jun 30, 2026 ↗ |
| VANGUARD MID-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,022,888 | 307.9M $ | 0.88 % | 0.76 % | as of Jun 30, 2026 ↗ |
| New Perspective Fund New Perspective Fund | 1,020,320 | 307.1M $ | 0.18 % | 0.76 % | as of Jun 30, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 955,780 | 288.6M $ | 0.12 % | 0.71 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 942,174 | 283.6M $ | 3.12 % | 0.70 % | as of Jun 30, 2026 ↗ |
| American Balanced Fund American Balanced Fund | 800,000 | 240.8M $ | 0.08 % | 0.60 % | as of Jun 30, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 786,679 | 236.8M $ | 1.10 % | 0.59 % | as of Jun 30, 2026 ↗ |
| New Economy Fund New Economy Fund | 723,459 | 218.5M $ | 0.42 % | 0.54 % | as of May 31, 2026 ↗ |
| Ultra Fund American Century Mutual Funds, Inc. | 688,000 | 141.4M $ | 0.55 % | 0.51 % | as of Jul 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 684,324 | 206.7M $ | 0.48 % | 0.51 % | as of May 31, 2026 ↗ |
| Fidelity Advisor Growth Opportunities Fund Fidelity Advisor Series I | 635,135 | 191.8M $ | 0.54 % | 0.47 % | as of May 31, 2026 ↗ |
| Capital Group Growth ETF Capital Group Growth ETF | 613,330 | 185.2M $ | 0.76 % | 0.46 % | as of May 31, 2026 ↗ |
| JPMorgan Mid Cap Growth Fund JPMorgan Trust II | 605,988 | 182.4M $ | 1.38 % | 0.45 % | as of Jun 30, 2026 ↗ |
| American Funds Fundamental Investors American Funds Fundamental Investors | 600,000 | 180.6M $ | 0.10 % | 0.45 % | as of Jun 30, 2026 ↗ |
| Invesco NASDAQ 100 ETF Invesco Exchange-Traded Fund Trust II | 563,667 | 170.2M $ | 0.18 % | 0.42 % | as of May 31, 2026 ↗ |
| VANGUARD U.S. GROWTH FUND VANGUARD WORLD FUND | 554,294 | 167.4M $ | 0.35 % | 0.41 % | as of May 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 548,234 | 165M $ | 0.29 % | 0.41 % | as of Jun 30, 2026 ↗ |
| iShares MSCI USA Min Vol Factor ETF iShares Trust | 519,903 | 106.9M $ | 0.45 % | 0.39 % | as of Jul 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 511,683 | 154.5M $ | 2.93 % | 0.38 % | as of May 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 509,032 | 153.2M $ | 0.12 % | 0.38 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 505,045 | 103.8M $ | 0.20 % | 0.38 % | as of Jul 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 478,850 | 144.1M $ | 0.94 % | 0.36 % | as of Jun 30, 2026 ↗ |
| Asset Allocation Fund AMERICAN FUNDS INSURANCE SERIES | 460,972 | 138.8M $ | 0.49 % | 0.34 % | as of Jun 30, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 460,000 | 138.9M $ | 2.40 % | 0.34 % | as of May 31, 2026 ↗ |
| Heritage Fund American Century Mutual Funds, Inc. | 450,954 | 92.7M $ | 1.74 % | 0.34 % | as of Jul 31, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 442,665 | 91M $ | 0.09 % | 0.33 % | as of Jul 31, 2026 ↗ |
| JPMorgan Growth Advantage Fund J.P. Morgan Mutual Fund Investment Trust | 409,574 | 123.3M $ | 0.55 % | 0.31 % | as of Jun 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 396,853 | 119.8M $ | 0.63 % | 0.30 % | as of May 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 387,186 | 79.6M $ | 3.62 % | 0.29 % | as of Jul 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 367,813 | 111.1M $ | 0.40 % | 0.27 % | as of May 31, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 350,780 | 105.6M $ | 0.37 % | 0.26 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 341,887 | 102.9M $ | 0.96 % | 0.26 % | as of Jun 30, 2026 ↗ |
| Growth-Income Fund AMERICAN FUNDS INSURANCE SERIES | 341,194 | 102.7M $ | 0.22 % | 0.25 % | as of Jun 30, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 315,780 | 95.1M $ | 0.05 % | 0.24 % | as of Jun 30, 2026 ↗ |
| Federated Hermes MDT Mid Cap Growth Fund Federated Hermes Equity Funds | 313,706 | 64.5M $ | 0.98 % | 0.23 % | as of Jul 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 303,631 | 91.7M $ | 0.37 % | 0.23 % | as of May 31, 2026 ↗ |
| MFS Mid Cap Growth Fund MFS Series Trust IV | 285,915 | 86.3M $ | 0.63 % | 0.21 % | as of May 31, 2026 ↗ |
| Schwab U.S. Large-Cap Growth ETF SCHWAB STRATEGIC TRUST | 282,385 | 85.3M $ | 0.14 % | 0.21 % | as of May 31, 2026 ↗ |
| JPMorgan Nasdaq Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust | 279,874 | 84.3M $ | 0.21 % | 0.21 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 270,000 | 55.5M $ | 1.78 % | 0.20 % | as of Jul 31, 2026 ↗ |
| American Funds Global Balanced Fund American Funds Global Balanced Fund | 269,513 | 55.4M $ | 0.17 % | 0.20 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 266,374 | 80.2M $ | 0.67 % | 0.20 % | as of Jun 30, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 257,986 | 77.7M $ | 0.26 % | 0.19 % | as of Jun 30, 2026 ↗ |
| Fundamental Large Cap Core Fund John Hancock Investment Trust | 254,218 | 52.2M $ | 0.87 % | 0.19 % | as of Jul 31, 2026 ↗ |
| ClearBridge Growth Fund Legg Mason Partners Investment Trust | 252,200 | 76.2M $ | 1.82 % | 0.19 % | as of May 29, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 250,647 | 75.7M $ | 0.05 % | 0.19 % | as of May 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 248,396 | 74.8M $ | 1.01 % | 0.19 % | as of Jun 30, 2026 ↗ |
| Carillon Eagle Mid Cap Growth Fund Carillon Series Trust | 240,980 | 72.5M $ | 1.39 % | 0.18 % | as of Jun 30, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 235,602 | 70.9M $ | 2.52 % | 0.18 % | as of Jun 30, 2026 ↗ |
| JPMorgan Large Cap Growth Fund JPMorgan Trust II | 211,216 | 63.6M $ | 0.05 % | 0.16 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 209,345 | 63.2M $ | 0.12 % | 0.16 % | as of May 31, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 208,097 | 62.6M $ | 0.89 % | 0.16 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 205,259 | 61.8M $ | 0.40 % | 0.15 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 202,780 | 61.2M $ | 0.05 % | 0.15 % | as of May 31, 2026 ↗ |
| AP7 Aktiefond Sjunde AP-fonden | 200,888 | 633.2M SEK | 0.05 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity OTC K6 Portfolio Fidelity Securities Fund | 189,512 | 38.9M $ | 1.06 % | 0.14 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Equity Growth Fund Fidelity Advisor Series I | 187,899 | 56.7M $ | 0.42 % | 0.14 % | as of May 31, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 183,160 | 55.1M $ | 1.12 % | 0.14 % | as of Jun 30, 2026 ↗ |
| ClearBridge Value Fund Legg Mason Global Asset Management Trust | 180,000 | 37M $ | 0.87 % | 0.13 % | as of Jul 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 175,498 | 36.1M $ | 0.09 % | 0.13 % | as of Jul 31, 2026 ↗ |
| ClearBridge Large Cap Growth Fund Legg Mason Partners Investment Trust | 173,840 | 52.5M $ | 0.50 % | 0.13 % | as of May 29, 2026 ↗ |
| VIP Growth Portfolio Variable Insurance Products Fund | 173,124 | 52.1M $ | 0.42 % | 0.13 % | as of Jun 30, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 172,048 | 51.8M $ | 0.06 % | 0.13 % | as of Jun 30, 2026 ↗ |
| BlackRock Mid-Cap Growth Equity Portfolio BlackRock Funds | 167,928 | 50.7M $ | 0.90 % | 0.13 % | as of May 29, 2026 ↗ |
| JNL/JPMorgan MidCap Growth Fund JNL Series Trust | 165,556 | 49.8M $ | 1.40 % | 0.12 % | as of Jun 30, 2026 ↗ |
| JNL/Loomis Sayles Global Growth Fund JNL Series Trust | 162,314 | 48.9M $ | 2.44 % | 0.12 % | as of Jun 30, 2026 ↗ |
| Dodge & Cox Global Stock Fund Dodge & Cox Funds | 161,841 | 48.7M $ | 0.37 % | 0.12 % | as of Jun 30, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 160,313 | 48.3M $ | 1.10 % | 0.12 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Large Cap Stock Fund Fidelity Hastings Street Trust | 158,850 | 47.8M $ | 0.17 % | 0.12 % | as of Jun 30, 2026 ↗ |
| Franklin Small-Mid Cap Growth Fund Franklin Strategic Series | 158,320 | 32.5M $ | 0.94 % | 0.12 % | as of Jul 31, 2026 ↗ |
| VANGUARD LARGE-CAP INDEX FUND VANGUARD INDEX FUNDS | 155,927 | 46.9M $ | 0.06 % | 0.12 % | as of Jun 30, 2026 ↗ |
| Nomura Mid Cap Growth Fund IVY FUNDS | 148,058 | 44.6M $ | 1.49 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 143,957 | 43.3M $ | 0.89 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 142,642 | 42.9M $ | 1.09 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Schwab U.S. Large-Cap ETF SCHWAB STRATEGIC TRUST | 140,507 | 42.4M $ | 0.06 % | 0.11 % | as of May 31, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 137,700 | 41.5M $ | 0.04 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Strategies Fund Fidelity Mt. Vernon Street Trust | 135,280 | 40.9M $ | 0.94 % | 0.10 % | as of May 31, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 132,270 | 39.8M $ | 1.54 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Fundamental All Cap Core Trust John Hancock Variable Insurance Trust | 128,322 | 38.6M $ | 1.59 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Mid Cap Core ETF Fidelity Covington Trust | 127,908 | 38.5M $ | 0.52 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Focused Dynamic Growth Fund American Century Growth Funds, Inc. | 125,272 | 25.7M $ | 1.29 % | 0.09 % | as of Jul 31, 2026 ↗ |
| Capital Group Core Balanced ETF Capital Group Core Balanced ETF | 119,517 | 36M $ | 0.51 % | 0.09 % | as of Jun 30, 2026 ↗ |
| First Trust Nasdaq-100 Select Equal Weight ETF First Trust Exchange-Traded Fund | 117,806 | 35.5M $ | 1.96 % | 0.09 % | as of Jun 30, 2026 ↗ |
| VIP Growth Opportunities Portfolio Variable Insurance Products Fund III | 116,251 | 35M $ | 0.66 % | 0.09 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 115,173 | 34.7M $ | 0.24 % | 0.09 % | as of Jun 30, 2026 ↗ |
| Touchstone Strategic Trust-Touchstone Mid Cap Growth Fund Touchstone Strategic Trust | 113,088 | 34M $ | 1.50 % | 0.08 % | as of Jun 30, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.16 % | as of Sep 30, 2025 ↗ |
| Fidelity Funds - Global Healthcare Fund FIL Investment Management (Luxembourg) S.A. | 1.61 % | as of Apr 30, 2025 ↗ |
| Pictet - Quest AI-Driven Global Equities Pictet Asset Management (Europe) S.A. | 0.36 % | as of Sep 30, 2025 ↗ |
| Amundi Dynamique Climat Amundi Asset Management | 0.03 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 3.99 % | as of Dec 31, 2025 ↗ |
| Corgi Genomics & Precision Medicine ETF Corgi ETF Trust I | 3.88 % | as of Jun 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 3.83 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 3.62 % | as of Jul 31, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 3.42 % | as of Jun 30, 2026 ↗ |
| American Century Mid Cap Growth Impact ETF American Century ETF Trust | 3.19 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3.19 % | as of May 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 3.17 % | as of Jul 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.16 % | as of Sep 30, 2025 ↗ |
| iShares Biotechnology ETF iShares Trust | 3.12 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 673 | -23 | 75,027,811 | -0.5 % |
| 2026Q2 | 696 | +10 | 75,428,168 | +1.0 % |
| 2026Q1 | 686 | +34 | 74,668,226 | +1.3 % |
| 2025Q4 | 652 | +34 | 73,684,788 | -2.6 % |
| 2025Q3 | 618 | -6 | 75,686,877 | +2.2 % |
| 2025Q2 | 624 | +46 | 74,063,375 | -0.1 % |
| 2025Q1 | 578 | -8 | 74,152,711 | -1.2 % |
| 2024Q4 | 586 | +51 | 75,034,343 | +9.1 % |
| 2024Q3 | 535 | +19 | 68,756,140 | +5.3 % |
| 2024Q2 | 516 | -5 | 65,297,179 | +1.9 % |
| 2024Q1 | 521 | -7 | 64,072,072 | -8.1 % |
| 2023Q4 | 528 | 69,739,098 |
Institutional managers
775 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 14,579,166 | 4.8B $ | as of Mar 31, 2026 |
| Capital World Investors | 10,802,348 | 3.6B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 10,444,908 | 3.5B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 9,471,181 | 3.1B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 6,323,752 | 2B $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,193,324 | 1.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,322,698 | 1.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,660,385 | 884.6M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 2,493,866 | 825.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,992,577 | 659.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,935,925 | 640.5M $ | as of Mar 31, 2026 |
| Dodge & Cox | 1,929,253 | 638.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,802,363 | 596.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,432,748 | 474.1K $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 1,356,036 | 448.7M $ | as of Mar 31, 2026 |
| Orbis Allan Gray Ltd | 1,334,825 | 441.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,291,726 | 427.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,099,318 | 363.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,059,062 | 350.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,002,681 | 331.8M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 966,912 | 319.9M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 934,881 | 309.3M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 913,104 | 297.9M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 858,120 | 283.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 838,187 | 277.3M $ | as of Mar 31, 2026 |
Funds holding the debt of ALNYLAM PHARMACEUTICALS INC
39 funds declare 48 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of ALNYLAM PHARMACEUTICALS INC". https://titelia.com/en/stocks/alnylam-pharmaceuticals-inc-US02043Q1076